In the 3 patients with myopathy (Pt1, Pt2, and Pt3) only Pt3 showed some residual presence of functional glycogenin-1 because a faint band was detected, but only after α-amylase treatment (Fig. 3A). Here, GYG1 is linked to myopathy.